Paper Details

  1. Home
  2. Paper Details

Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.

Author: , DelbelloMelissa P, GlickIra, GreenAlan I, HamerRobert M, JohnsonJacqueline L, LiebermanJeffrey A, PatelJayendra K, StrakowskiStephen M, TohenMauricio

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Schizophrenia severely affects quality of life. While treatments have improved, focus now shifts towards helping patients rejoin society, not just managing symptoms. The development of newer antipsychotic medications offered hope for better quality of life, especially early in the illness.
Paper Details　
Original Abstract of the Article :
Schizophrenia causes significant impairments of quality of life. As treatment approaches have advanced, more attention has been given to re-integrating patients into their psychosocial environments, rather than simply monitoring psychotic symptoms. The development of the second-generation antipsycho...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.schres.2005.04.017

データ提供：米国国立医学図書館（NLM）

Quality of Life in Schizophrenia: Finding Oasis in the Desert of Symptoms

Schizophrenia is a complex and challenging mental health condition, often leaving individuals feeling lost and isolated in a vast and unforgiving desert of symptoms. This research explores the impact of different antipsychotic medications on quality of life in individuals experiencing their first psychotic episode. It's like searching for oases of well-being and resilience in the midst of a challenging journey.

Beyond Symptoms: Measuring the Impact on Quality of Life

The study found that individuals treated with olanzapine, a second-generation antipsychotic, experienced greater improvements in quality of life compared to those treated with haloperidol, a conventional antipsychotic. It's like finding a more hospitable oasis, offering a greater sense of peace and well-being. The researchers emphasize the importance of considering quality of life alongside symptom reduction, recognizing the multifaceted nature of mental health and the need for treatments that support overall well-being.

Hope in the Desert: Empowering Individuals to Thrive

This research highlights the importance of tailoring treatment approaches to address the unique needs of individuals with schizophrenia, focusing not only on symptom management but also on improving their overall quality of life. It's like finding a path through the desert that leads to a more fulfilling and meaningful life. The study encourages clinicians to consider the long-term impact of treatments on patients' well-being, empowering them to live more fulfilling lives despite the challenges they face.

Dr. Camel's Conclusion

This study is a reminder that treating mental illness is not just about reducing symptoms but also about improving overall quality of life. The findings highlight the importance of considering the multifaceted nature of mental health and the need for treatments that support both symptom management and personal well-being. It's a beacon of hope in the desert of schizophrenia, reminding us that with tailored care and ongoing support, individuals can find oases of resilience and joy, enabling them to thrive despite the challenges they face.

Date :
  1. Date Completed 2006-01-13
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

15950436

DOI: Digital Object Identifier

10.1016/j.schres.2005.04.017

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.